4//SEC Filing
ROSENBERG MORRIS 4
Accession 0001203311-12-000026
CIK 0001060736other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 7:30 PM ET
Size
8.3 KB
Accession
0001203311-12-000026
Insider Transaction Report
Form 4
ROSENBERG MORRIS
EVP, Development
Transactions
- Exercise/Conversion
Common Stock
2012-04-20$5.63/sh+38,281$215,522→ 55,924 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2012-04-20−38,281→ 0 totalExercise: $5.63Exp: 2016-01-31→ Common Stock (38,281 underlying) - Sale
Common Stock
2012-04-20$19.51/sh−38,281$746,862→ 17,643 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Rosenberg on March 15, 2012.
- [F2]Amount of securities beneficially owned following reported transactions includes 17,643 Restricted Stock Units subject to vesting.
- [F3]Shares shall vest at a rate of 25% on 1/31/07 and monthly thereafter until all the shares are fully vested on 1/31/10.
Documents
Issuer
SEATTLE GENETICS INC /WA
CIK 0001060736
Entity typeother
Related Parties
1- filerCIK 0001202786
Filing Metadata
- Form type
- 4
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 7:30 PM ET
- Size
- 8.3 KB